ovascular therapy of the
distal aortic arch: preliminary results of the feasibility
multicenter trial of the Gore thoracic branch endoprosthesis. Ann Thorac Surg 2016;102:1190-8.
157. Roselli EE, Arko FR 3rd, Thompson MM. Results of the
Valiant Mona LSA early feasibility study for descending
thoracic aneurysms. J Vasc Surg 2015;62:1465-71.e3.
158. Drews JD, Patel HJ, Williams DM, Dasika NL, Deeb GM. The
impact of acute renal failure on early and late outcomes
after thoracic aortic endovascular repair. Ann Thorac Surg
2014;97:2027-33.
159. Piffaretti G, Mariscalco G, Bonardelli S, Sarcina A, Gelpi G,
Bellosta R, et al. Predictors and outcomes of acute kidney
injury after thoracic aortic endograft repair. J Vasc Surg
2012;56:1527-34.
160. Silver SA, Shah PM, Chertow GM, Harel S, Wald R, Harel Z.
Risk prediction models for contrast induced nephropathy:
systematic review. BMJ 2015;351:h4395.
161. Wichmann JL, Katzberg RW, Litwin SE, Zwerner PL, De
Cecco CN, Vogl TJ, et al. Contrast-induced nephropathy.
Circulation 2015;132:1931-6.
162. Eng J, Wilson RF, Subramaniam RM, Zhang A, SuarezCuervo C, Turban S, et al. Comparative effect of contrast
media type on the incidence of contrast-induced nephropathy: a systematic review and meta-analysis. Ann
Intern Med 2016;164:417-24.

82S

Upchurch et al

Journal of Vascular Surgery
January Supplement 2021

163. Wang N, Qian P, Kumar S, Yan TD, Phan K